Compass news archive
Read our latest news and updates.
For media inquiries, contact us at media@compasspathways.com
-
January 04, 2022
A New Year message to our community
Read article
-
January 04, 2022
COMP360 psilocybin study of 89 healthy participants published in Journal of Psychopharmacology
Read article
-
December 17, 2021
Compass selected for addition to NASDAQ Biotechnology Index
Read article
-
December 16, 2021
Our team’s highlights and reflections from 2021
Read article
-
December 16, 2021
Compass Pathways announces changes in Executive Team
Read article
-
December 13, 2021
Compass Pathways announces positive outcome of 25mg COMP360 psilocybin therapy as adjunct to SSRI an...
Read article
-
December 06, 2021
George and Ekaterina at Meet Delic 2021
Read article
-
December 03, 2021
Michael Falvey joins Compass Pathways as Chief Financial Officer
Read article
-
December 01, 2021
Compass Pathways announces further positive results from groundbreaking phase 2b trial of investigat...
Read article
-
November 23, 2021
Compass Pathways granted fifth US patent for crystalline psilocybin
Read article
-
November 09, 2021
Compass Pathways announces positive topline results from groundbreaking phase 2b trial of investigat...
Read article
-
November 09, 2021
Compass Pathways plc announces financial results and business highlights for the third quarter 2021
Read article
-
November 03, 2021
Compass Pathways to launch phase 2 trial of COMP360 psilocybin therapy for post-traumatic stress dis...
Read article
-
October 22, 2021
Our wellbeing programme at Compass
Read article
-
October 20, 2021
Open-label study of COMP360 psilocybin therapy for depression in cancer patients demonstrates feasib...
Read article
-
October 19, 2021
Compass Pathways is granted new US patent for crystalline psilocybin
Read article
-
September 14, 2021
Compass Pathways acquires IP portfolio of novel psychedelic compounds and prodrugs
Read article
-
September 10, 2021
Hamilton Morris joins Compass Pathways to research new psychedelic compounds
Read article
-
September 08, 2021
Ecosia: the search engine that plants trees
Read article
-
August 18, 2021
Completing our phase IIb clinical trial
Read article
-
August 13, 2021
White Paper 2021
Read article
-
August 11, 2021
Compass Pathways plc announces financial results and business highlights for the second quarter 2021
Read article
-
July 29, 2021
Guy Goodwin joins Compass Pathways as Chief Medical Officer
Read article
-
July 21, 2021
Danielle Schlosser joins Compass Pathways from Verily Life Sciences to lead clinical innovation and ...
Read article
-
July 05, 2021
Compass Pathways joins forces with King’s College London and South London and Maudsley NHS Founda...
Read article
-
June 30, 2021
Compass Pathways launches new podcast “Everyone has a story: talking about mental health”
Read article
-
June 28, 2021
Compass Pathways completes COMP360 psilocybin therapy administration for 216 patients in large-scale...
Read article
-
June 23, 2021
Compass Pathways becomes Founding Supporter of the British Neuroscience Association’s inaugural Sc...
Read article
-
June 11, 2021
Compass Pathways plc to participate in JMP Securities and H.C. Wainwright investor conferences
Read article
-
June 03, 2021
Compass Pathways and Kings College London publish cognition results from COMP360 psilocybin study in...
Read article